🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07732725
Starting soon Phase EARLY_PHASE1

Comparison Between the Effect of Two Different Doses of Oral Melatonin on Sleep Quality After Total Hip Arthroplasty

NCT07732725 · tracked via the Priya Life Science Egypt tracker
Phase
Phase EARLY_PHASE1
Started
2026-08-04
Last updated
2026-07-29

Condition(s) studied

Sleep Disturbance

Investigational drug(s) / intervention(s)

Melatonin 5 MG →Melatonin 10 MG →Placebo

Melatonin 5 MG: Melatonin 5 mg and one placebo sugar tablet oral tablet, two hours preoperatively and for 14 nights postoperatively.

Melatonin 10 MG: Two melatonin 5 mg oral tablet, two hours preoperatively and for 14 nights postoperatively.

Placebo: Two placebo sugar tablets, two hours preoperatively and for 14 nights postoperatively.

Study summary

Considering the fact that melatonin was safely and effectively used in higher doses in multiple surgical conditions , the present study hypothesized that increasing melatonin dose in THA would have better benefits for patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Elective unilateral total hip arthroplasty. Exclusion Criteria: * Revision arthroplasty * documented sleep disorders requiring treatment, * use of other sleep medications preoperatively * known melatonin allergy or contraindication.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Benha Univeristy Banhā Qalyobua

More Benha University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07732725 on ClinicalTrials.gov ↗ ← All trials in Egypt